Xtant Medical Holdings Inc. (XTNT)
XTNT trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1453593/000149315226013792/0001493152-26-013792-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | XTNT on NYSE |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001453593 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $133.9M |
| Net income | $5.0M |
| Operating income | $7.3M |
| Net margin | 3.7% |
| Operating margin | 5.4% |
| Revenue growth | +14.2% |
| Cash | $17.1M |
| Total assets | $94.1M |
| P/E (computed) | 5.9× |
| P/S (computed) | 0.2× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-08-11 |
| Cash and burn | $9.9M cash; operating cash flow $143K a quarter. | Report 2026-06-30 |
| Shares outstanding | 140,287,960 (2026-08-07); 130,315,722 a year earlier; 128,897,048 three years earlier. | Cover page 2026-08-07 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Grant Thornton LLP, Minneapolis, Minnesota, United States | PCAOB Form AP 2026-04-02 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | $23.0M | -$9.4M | -$7.3M | $9.9M | $7.3M | $109.5M | 10-Q 2026-08-11 |
| Q1 2026 2026-03-31 | $20.9M | -$3.1M | -$2.1M | $12.1M | $8.1M | $121.9M | 10-Q 2026-05-13 |
| Q4 2025 2025-12-31 | $32.4M | $57K | $5.4M | $17.1M | $11.0M | $133.9M | 10-K 2026-03-31 |
| Q3 2025 2025-09-30 | $33.3M | $1.3M | $4.6M | $10.4M | $17.4M | $133.1M | 10-Q 2025-11-10 |
| Q2 2025 2025-06-30 | $35.4M | $3.5M | $1.3M | $6.9M | $22.3M | $127.8M | 10-Q 2026-08-11 |
| Q1 2025 2025-03-31 | $32.9M | $58K | $1.3M | $5.0M | $22.2M | $122.3M | 10-Q 2026-05-13 |
| Q4 2024 2024-12-31 | $31.5M | -$3.2M | $665K | $6.2M | $22.0M | $117.3M | 10-K 2026-03-31 |
| Q3 2024 2024-09-30 | $27.9M | -$5.0M | -$1.7M | $6.6M | $19.1M | $113.9M | 10-Q 2025-11-10 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2025-05-20 |
| Latest annual report | 10-K | 2026-03-31 |
| Latest quarterly / interim | 10-Q | 2026-11-16 |
| Latest current report | 8-K | 2026-11-16 |
| Latest proxy | DEFA14A | 2026-06-23 |
Source: SEC EDGAR submissions feed, 1,003 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -6.9% |
| 1 month | -15.6% |
| 3 months | -12.9% |
| Year to date | -65.4% |
| 1 year | -59.1% |
| From 52-week high | -66.7% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NSPR | InspireMD Inc. | $0.6000 | -6.85% | $28.1M |
| NEPH | Nephros Inc. | $3.00 | -1.64% | $32.6M |
| PLRZ | Polyrizon Ltd. | $10.70 | -2.37% | $26.0M |
| DAVI | Davion Healthcare Plc | $1.02 | +2.00% | $25.5M |
| TELA | TELA Bio Inc. | $0.7616 | -7.13% | $34.4M |
| BEAT | Heartbeam Inc. | $0.3590 | -9.23% | $22.7M |
| SRTS | Sensus Healthcare Inc. | $2.34 | +0.65% | $38.5M |
| MDAI | Spectral AI Inc. | $1.31 | +0.77% | $42.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier